Chinese insurers and their bank partners have halted sales of popular high-yielding investment products in recent days under pressure from regulators, signalling that the explosive growth in premiums that fuelled the industry’s aggressive acquisition spree in recent years is set to slow.
迫于监管压力，manbetx3.0 保险公司及其银行合作伙伴近日已停售颇受欢迎的高收益投资产品，这表明推动最近几年manbetx3.0 保险业激进收购浪潮的保费收入的爆炸性增长将放缓。
您已阅读8%（362字），剩余92%（3984字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。